June 7, 2017 - By Richard Conner
Among 7 analysts covering Orange (NYSE:ORAN), 3 have Buy rating, 0 Sell and 4 Hold. Therefore 43% are positive. Orange had 9 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was downgraded by Bank of America to “Neutral” on Wednesday, August 31. As per Monday, April 4, the company rating was downgraded by Deutsche Bank. The rating was downgraded by Deutsche Bank to “Hold” on Tuesday, July 21. As per Wednesday, August 26, the company rating was upgraded by Citigroup. The firm has “Outperform” rating by Credit Suisse given on Tuesday, September 27. The stock of Orange SA (ADR) (NYSE:ORAN) earned “Outperform” rating by Raymond James on Tuesday, July 19. HSBC upgraded Orange SA (ADR) (NYSE:ORAN) on Tuesday, January 17 to “Buy” rating. The firm has “Hold” rating by HSBC given on Monday, October 3. The firm has “Hold” rating by Berenberg given on Monday, January 23. See Orange SA (ADR) (NYSE:ORAN) latest ratings:
23/01/2017 Broker: Berenberg Rating: Hold Initiate
17/01/2017 Broker: HSBC Old Rating: Hold New Rating: Buy Upgrade
Tekla Capital Management Llc decreased Retrophin Inc. (RTRX) stake by 49.1% reported in 2016Q4 SEC filing. Tekla Capital Management Llc sold 162,000 shares as Retrophin Inc. (RTRX)’s stock declined 17.61%. The Tekla Capital Management Llc holds 167,949 shares with $3.18 million value, down from 329,949 last quarter. Retrophin Inc. now has $680.40M valuation. The stock rose 0.74% or $0.13 reaching $17.61. About 38,443 shares traded. Retrophin Inc (NASDAQ:RTRX) has risen 4.93% since June 7, 2016 and is uptrending. It has underperformed by 11.77% the S&P500.
About 162,405 shares traded. Orange SA (ADR) (NYSE:ORAN) has risen 1.61% since June 7, 2016 and is uptrending. It has underperformed by 15.09% the S&P500.
Orange SA is a telecommunications operator. The company has market cap of $44.57 billion. The Firm also provides telecommunication services to multinational companies, under the brand Orange Business Services. It has a 59.26 P/E ratio. The Company’s divisions include France, Spain, Poland, Belgium and Luxembourg, Central European countries, Africa and Middle East, Enterprise, and International Carriers & Shared Services.
Tekla Capital Management Llc increased Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) stake by 31,900 shares to 795,905 valued at $97.38M in 2016Q4. It also upped New Senior Investment Group Inc. (NYSE:SNR) stake by 137,000 shares and now owns 567,997 shares. Senior Housing Properties Trust (NYSE:SNH) was raised too.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.